Risk of hepatobiliary disease in adults with severe α1-antitrypsin deficiency (PiZZ): Is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 10, 1996, Pages 989-994

  Elzouki, Abdul Nasser ^a   Eriksson, Sten ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cirrhosis; Gallbladder disease; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOPSY; CHOLELITHIASIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; RISK FACTOR; SWEDEN;

EID: 0029974035     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199610000-00010     Document Type: Article

References (36)

1. Cox DW: α-1-antitrypsin deficiency. In The Metabolic Basis of Inherited Disease. Edited by Charles R, Scrivel G. New York: McGraw-Hill; 1989:2409-2437.
2. Larsson C: Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, PiZ. Acta Med Scand 1978, 204:345-351.
3. Cox DW, Smyth S: Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med 1983, 74:221-227.
4. Eriksson S, Carlson J, Velez R: Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986, 314:736-739.
5. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W: High prevalence of viral infection in adults with homozyα gous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992, 117:641-645.
6. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W: Prevalence of hepatocellular carcinoma in alpha 1-antiα trypsin deficiency. J Hepatol 1994, 21:1006-1011.
7. Montanelli A, Barberis D, Montanini C, Costa E: Alpha 1-antitrypsin deficiency and viral infections. Vox Sang 1993, 65:332-333.
8. Elzouki A-N, Verbaan H, Eriksson S: Alpha 1-antitrypsin and alpha 1-antichymotrypsin deficiencies in chronic hepatitis C infection. J Hepatol 1995, 23(suppl. 1):93.
9. Hofman AF: Primary and secondary prevention of gallstone disease: implications for patient managment and research priorities. Am J Surg 1993, 165:541-548.
10. Acalovschi M, Badea R, Dumitrascu D, Varga C: Prevalence of gallstones in liver cirrhosis: a sonographic survey. Am J Gastroenterol 1988, 83:954-956.
11. Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, et al.: Cirrhosis of the liver. A risk factor for development of cholelithiasis in males. Dig Dis Sci 1990, 35:1403-1408.
12. Fornari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, et al.: Incidence of gallstones in a population of patients with cirrhosis. J Hepatol 1994, 20:797-801.
13. 1-proteinase inhibitor. FEBS Lett 1994, 343:141-145.
14. 1-antitrypsin. Biol Chem Hoppe-Seyler 1995, 375:103-109.
15. 1-antitrypsin. J Hepatol 1995, 23(suppl. 1):169.
16. 1-antitrypsin promotes cholesterol nucleation. J Hepatol 1995, 23(suppl. 1):164.
17. Berge T, Lundberg S: Cancer in Malmö 1958-1969: an autopsy study. Acta Pathol Microbiol Scand 1977, 260 (suppl.):1-234.
18. 1-antitrypsin of Pi type M, S and Z. Eur J Biochem 1978, 53:143-153.
19. Schlesselman JJ: Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press; 1982.
20. Mainland D: The risk of fallacious conclusions from autopsy data on the incidence of diseases with applications to heart disease. Am Heart J 1953, 45:644-654.
21. Eriksson S: Studies in ̈1-antitrypsin deficiency. Acta J Med Scand 1965, 177(suppl. 432):38-40.
22. Sveger T: Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200 000 infants. N Engl J Med 1976, 294:1316-1321.
23. Black LF, Kueppers F: Alpha 1-antitrypsin deficiency in nonsmokers. Am Rev Resp Dis 1978, 117:421-428.
24. Perlmutter DH: The cellular basis for liver injury in α1-antitrypsin deficiency. Hepatology 1991, 13:172-185.
25. Jeppsen JO: Amino acid substitution Glu-Lys in α1-antitrypsin deficiency PiZ. FEBS Lett 1976, 65:195-197.
26. Cox DW, Billingsley GD, Callahan JW: Aggregation of plasma Z type α1-antitrypsin suggests a basic defect for the deficiency. FEBS Lett 1986, 205:255-260.
27. Sharp HL: Alpha 1-antitrypsin deficiency. Hosp Pract 1971, 6:83-96.
28. Lomas DA, Evans DLI, Finch JT, Carrell RW: The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 1992, 357:605-607.
29. Wu Y, Whitman F, Mobmenti E, Moore K, Hippenmeyer P, Perlmutter DH: A lag in intracellular degradation of mutant α1-antitrypsin correlated with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc Natl Acad Sci USA 1995, 91:9014-9018.
30. Sharp HL: Wherefore art thou liver disease associated with alpha-1-antitrypsin deficiency? Hepatology 1995, 22:666-668.
31. 1-antitrypsin. Biochemistry 1993, 32:500-508.
32. 1-antitrypsin and C1 protease inhibitor in human bile, plasma and spleen. FEBS Lett 1992, 299:146-148.
33. Bainton D, Davies GT, Evans KT, Gravelle IH: Gallbladder disease. Prevalence in a south Wales industrial town. New Engl J Med 1976, 294:1147-1151.
34. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO): The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. Hepatology 1988, 8:907-913.
35. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP: Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990, 131:836-844.
36. Zahor Z, Sternby NH, Kagan A, Uemura K, Vanecek R, Vichert DM: Frequency of cholelithiasis in Prague and Malmö. An autopsy study. Scand J Gastroenterol 1974, 9:3-7.